Ponezumab Uses, Dosage, Side Effects and more
Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).
| Trade Name | Ponezumab |
| Generic | Ponezumab |
| Ponezumab Other Names | PF-04360365, Ponezumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
